Continuous Positive Airway Pressure (CPAP) Devices Market-Rising Prevalence of Obstructive Sleep Apnea & Demand Accelerate the Growth of the Market

Pune, India, February 9, 2018/MRFR Press Release/- Market Research Future published a Half Cooked research report on “Global  Continuous Positive Airway Pressure (CPAP) Devices Market Research Report - Forecast to 2027” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2027.

Continuous Positive Airway Pressure (CPAP) Devices market-Overview

Continuous Positive Airway Pressure (CPAP) devices are used to provide assistance to the patients having obstructive sleep apnea (OSA) or sleep apnea in breathing. They are also used as a preventive and support device for patients with other diseases, such as acute asthma, congestive heart failure, cardiogenic pulmonary edema, cystic fibrosis, and chronic lung disease (CLD).

According to an updated report published by the Centre for Disease Control and Prevention (CDC) in 2017, a total number of deaths in the United States from chronic lower respiratory diseases is around 147,101 and is the third highest cause of death in the United States.

According to an updated report published by the Centre for Disease Control and Prevention (CDC) in 2017, around 3.5 million adults diagnosed with emphysema so far that is 1.5% of total the United States population and around 7,455 deaths occurred owing to emphysema till this year.

Chronic lower respiratory diseases are the major concern in the Americas. People diagnosed with respiratory diseases have higher chances of acquiring serious health complications such as memory loss, arthritis, congestive heart failure, diabetes, and premature death.

The global CPAP devices market is expected to exhibit exponential growth over the forecasted period due to increasing prevalence of sleep apnea, respiratory diseases and rapidly developing medical device industry. Furthermore, the market growth is supported by increasing healthcare expenditure and growing need for CPAP devices. America is expected to be the leading market during the forecasted period. However, high cost of the devices and poor reimbursement policies may slower the market growth.

Access Report Deatails @ https://www.marketresearchfuture.com/reports/continuous-positive-airway-pressure-devices-market-939 

Key players in the Continuous Positive Airway Pressure (CPAP) Devices market    

Medtronic (U.S.), Koninklijke Philips N.V. (the Netherlands), 3B Medical, Inc. (U.S.), Armstrong Medical Inc. (U.S.), ResMed (U.S.), Smiths Medical (U.S.), Apex Medical Corp. (Taiwan), Fisher & Phillips LLP (U.S.), Cardinal Health (U.S.), Beijing Dehaier Medical Technology Co., Ltd. (China), DeVilbiss Healthcare LLC (U.S.), and Invacare Corporation (U.S.).

Key developments

Strategic approaches adopted help the major players to sustain their growth in the market and develop their business in various geographical areas across the globe. Agreements and collaborations, mergers and acquisitions, and new product launches are various strategies followed by the key players.

Koninklijke Philips N.V., headquartered in the Netherlands, focuses on manufacturing of electronics and healthcare products. The company manufactures a number of different CPAP devices used in hospital and at home.

System One Sleep device is one of the most widely used device of the company.

November, 2017: Koninklijke Philips N.V. launched new MR Solutions to support diagnostic procedures

November, 2017: Koninklijke Philips N.V. acquired Analytical Informatics, Inc. to enhance clinical and operational performance of imaging departments

June, 2017: Koninklijke Philips N.V. has acquired Electrical Geodesics a US-based medical device company that designs, develops and commercializes a range of non-invasive technologies

February, 2015: Koninklijke Philips N.V. completed the acquisition of Volcano

3B Medical, Inc.

3B Medical, Inc.  is one of the leading manufacturers of the medical devices. In 2015, the company has launched Luna PAP System used in the sleep therapy. Additionally, RESmart is another major product of the company used in sleep therapy.

Medtronic:

Medtronic is a public limited medical device company. Its headquarters are in Dublin, Ireland. This company is investing heavily in neuromodulation devices. 

October, 2017: Medtronic received FDA approval & U.S. launch of next generation pacemakers (Azure)

October, 2017: Medtronic and Mercy announced sharing partnership to accelerate medical device innovation

April, 2016: Medtronic received FDA approval for world's smallest pacemaker for U.S. patients

April, 2016: Medtronic launched new endoscopic ablation catheter for Barrett's Esophagus

October, 2016: Medtronics plc. received an approval for its suite of cardiac rhythm and heart failure devices and leads to be scanned in both 3 and 1.5 Tesla (T) magnetic resonance imaging (MRI) machines. This FDA approval will help the company to strengthen its position in MRI machines segment.

December, 2015: Medtronic plc. and Samsung came together in an alliance to accelerate the development of digital health solutions for the millions of people suffering from chronic pain, movement disorders, incontinence, and other conditions who could benefit from neuromodulation therapy. Due to this Medtronics seeks to deliver real-time data to the patients and the physicians so they effectively find the cure for the tracked symptoms.

In 2015: Medtronic plc. developed Stent Graft System for Endovascular Repair of Thoracoabdominal Aortic Aneurysms. Earlier company’s Resolute Drug-Eluting Stent has shown a very good performance in Diabetic Patients with Heart Disease.

Global Continuous Positive Airway Pressure (CPAP) Devices Market

North America dominates the Americas Continuous Positive Airway Pressure (CPAP) Devices market. North America is further segmented into the U.S. and Canada. The U.S. holds the major share of the market owing to a well-developed economy and the government support for research & development. South America is still a developing region in terms of the infrastructure and technology. Additionally, increasing awareness, development of innovative products and increasing use of portable devices for the treatment have been contributing to the growth of the market. According to the Centre for Disease Control and Prevention (2014), more than one third (36.5%) of America adults have obesity and obese people are more susceptible to sleep apnea, which, in turn, drive the market.

Additionally, rapid development of healthcare sector, large patient population, increasing health care spending and the concentration of major companies fuel the market growth.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com